Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen-
Envoyer une demande de publication
close

Demande de publication

Merci pour votre intérêt pour nos produits et votre demande concernant cette publication, qui vous sera envoyée si le chercheur et le journal l'autorisent. Notre équipe commerciale vous contactera rapidement.



Authors
R. Lalonde, M. Dumont, M. Staufenbiel, C. Strazielle.


Lab
Université de Rouen, Faculté de Médecine et de Pharmacie, INSERM U614, Rouen, France ; CHUM/St-Luc, Neuroscience Research Center, Montreal, Canada ; Novartis Institutes for Biomedical Research, Nervous System Research, Basel, Switzerland ; Université Henr

Journal
Behavioural Brain Research

Abstract
The SHIRPA primary screen comprises 40 measures covering various reflexes and basic sensorimotor functions. This multi-test battery was used to compare non-transgenic controls with APP23 transgenic mice, expressing the 751 isoform of human beta-amyloid precursor protein and characterized by amyloid deposits in parenchyma and vessel walls. The APP23 mice were distinguishable from controls by pathological limb reflexes, myoclonic jumping, seizure activity, and tail malformation. In addition, this mouse model of Alzheimer’s disease was also marked by a crooked swimming trajectory. APP23 mice were also of lighter weight and were less inclined to stay immobile during a transfer arousal test. Despite the neurologic signs, APP23 transgenic mice were not deficient in stationary beam, coat-hanger, and rotorod tests, indicating intact motor coordination abilities.

BIOSEB Instruments Used:
Aron Test or Four Plates Test (LE830),Rotarod (BX-ROD)

Partager ce contenu